Related Experiment Video
Updated: Oct 5, 2026

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
Published on: June 30, 2019
Reduced expression and impaired kinase activity of a Chk2 mutant identified in human lung cancer
S Matsuoka1, T Nakagawa, A Masuda
1Howard Hughes Medical Institute, Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030, USA. matsuoka@bcm.tmc.edu
Abstract:
The checkpoint kinase Chk2 is phosphorylated and activated in response to DNA damage such as ionizing radiation. Recently, we found a somatic mutation of CHK2 with clear loss of the wild-type allele in human lung cancer. Here we show that the mutant Chk2 exhibits modestly reduced in vitro kinase activity compared with wild type, whereas it is normally phosphorylated and activated after ionizing radiation. Interestingly, this mutant Chk2 protein was found to be less stable than wild type and could be expressed in various cell types only at a significantly reduced (20%) level of wild type. These findings confirm that the DNA damage checkpoint pathway involving CHK2 is indeed inactivated in this fatal adult cancer and also suggest that reduced expression of Chk2 may also be an important inactivating mechanism, contributing to the development of lung cancer.
Insights
Checkpoint kinase 2 (Chk2) mutations in lung cancer reduce its stability and expression, inactivating DNA damage repair pathways. This study confirms Chk2 pathway inactivation contributes to lung cancer development.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Checkpoint kinase 2 (Chk2) is crucial for DNA damage response.
- Somatic mutations in CHK2 have been identified in human lung cancer.
- The functional impact of these mutations on Chk2 activity and stability is not fully understood.
Purpose of the Study:
- To investigate the functional consequences of a CHK2 mutation found in lung cancer.
- To determine the effect of the mutation on Chk2 kinase activity, phosphorylation, and protein stability.
- To assess the role of Chk2 inactivation in lung cancer development.
Main Methods:
- In vitro kinase assays to compare wild-type and mutant Chk2 activity.
- Analysis of Chk2 phosphorylation and activation after ionizing radiation.
- Western blot analysis to determine protein expression levels and stability in various cell types.
Main Results:
- The CHK2 mutant showed modestly reduced in vitro kinase activity compared to wild type.
- Mutant Chk2 was normally phosphorylated and activated by ionizing radiation.
- Mutant Chk2 protein exhibited reduced stability, leading to significantly lower expression levels (20% of wild type).
Conclusions:
- The DNA damage checkpoint pathway involving Chk2 is inactivated in human lung cancer.
- Reduced Chk2 expression, due to decreased protein stability, is a significant mechanism contributing to lung cancer development.
- These findings highlight the importance of Chk2 in maintaining genomic stability and preventing lung tumorigenesis.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Inhibition of Cdk Activity
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...